Number of the records: 1
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors
- 1.Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
Leukemia. Roč. 16, č. 1 (2002), s. 67-73. ISSN 0887-6924. E-ISSN 1476-5551
Impact factor: 4.693, year: 2002
http://hdl.handle.net/11104/0087181
Number of the records: 1